Quantitative determination of odanacatib in human plasma using liquid–liquid extraction followed by liquid chromatography–tandem mass spectrometry analysis
Authors:
- Li SunLSLi Sun
- Sabrina ForniSFSabrina Forni
- Michael S. SchwartzMSMichael S. Schwartz
- Sheila BreidingerSBSheila Breidinger
- Eric J. WoolfEWEric J. Woolf
- 15 February 2012
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 885-886, 15-23
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Pharmacokinetics and Metabolism in Rats, Dogs, and Monkeys of the Cathepsin K Inhibitor Odanacatib: Demethylation of a Methylsulfonyl Moiety as a Major Metabolic PathwayDrug Metabolism and Disposition, 2011
- Peptidomimetic Inhibitors of Cathepsin KCurrent Topics in Medicinal Chemistry, 2010
- Odanacatib, a New Drug for the Treatment of Osteoporosis: Review of the Results in Postmenopausal WomenJournal of Osteoporosis, 2010
- 2009 White Paper on Recent Issues in Regulated Bioanalysis from The 3rd Calibration and Validation Group WorkshopBioanalysis, 2009
- Effect of the Cathepsin K Inhibitor Odanacatib on Bone Resorption Biomarkers in Healthy Postmenopausal Women: Two Double-Blind, Randomized, Placebo-Controlled Phase I StudiesClinical Pharmacology & Therapeutics, 2009
- Potential new drug targets for osteoporosisNature Clinical Practice Rheumatology, 2009
- The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin KBioorganic & Medicinal Chemistry Letters, 2008
- Standard line slopes as a measure of a relative matrix effect in quantitative HPLC–MS bioanalysisJournal of Chromatography B, 2006
- Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC−MS/MSAnalytical Chemistry, 2003
- Matrix Effect in Quantitative LC/MS/MS Analyses of Biological Fluids: A Method for Determination of Finasteride in Human Plasma at Picogram Per Milliliter ConcentrationsAnalytical Chemistry, 1998